Abstract

Simple SummaryTraditionally, it has been thought that control of body phosphorus was secondary to the tighter control of calcium. However, over the last 20 years, an extensive system for control of body phosphorus by proteins called phosphatonins has been shown to exist. Most research on phosphatonins has been done in rat or mouse models. This paper looks at whether important proteins and phosphorus channels in the phosphatonin pathways are present in the kidneys of dogs, horses and sheep. The results showed that all of the components of the phosphatonin system are present in these species, but that there are species differences in which protein or channel is most common, and in the relationships between the proteins and channels. This research is important because the phosphatonin system is involved in the progression of chronic kidney disease in humans and animals, and differences in the systems between animal species may affect treatment of chronic kidney disease.The aim of this preliminary study was to determine the relative expression of phosphatonin pathway-related genes in normal dog, sheep and horse kidneys and to explore the relationships between the different genes. Kidneys were collected post-mortem from 10 sheep, 10 horses and 8 dogs. RNA was extracted, followed by reverse transcriptase quantitative polymerase chain reaction for fibroblast growth factor receptor 1 IIIc (FGFR1IIIC), sodium-phosphate co-transporter (NPT) 1 (SLC17A1), NPT2a (SLC34A1), NPT2c (SLC34A3), parathyroid hormone 1 receptor (PTH1R), klotho (KL), vitamin D receptor (VDR), 1a-hydroxylase (CYP27B1) and 24-hydroxylase (CYP24A1). NPT2a was highly expressed in the dog kidneys, compared with those of the horses and sheep. NPT1 had greatest expression in horses and sheep, although the three different NPTs all had relatively similar expression in sheep. There was little variability in FGFR1IIIc expression, particularly in the dogs and horses. FGFR1IIIc expression was negatively correlated with NPT genes (except NPT2a in sheep), while NPT genes were all positively correlated with each other. Unexpectedly, klotho was positively correlated with NPT genes in all three species. These results provide the basis for further research into this important regulatory system. In particular, species differences in phosphatonin gene expression should be considered when considering the pathogenesis of chronic kidney disease.

Highlights

  • The traditional paradigm of body phosphorus control has been that regulation of phosphorus was secondary to the tighter control of calcium

  • This system is centered on fibroblast growth factor 23 (FGF23), a hormone that is produced by osteocytes in response to high plasma phosphorus concentrations [2]

  • FGF23 forms a complex with α-klotho and fibroblast growth factor receptor 1c (FGFR1c); limited binding to FGFR3 and -4 may occur [3,4]

Read more

Summary

Introduction

The traditional paradigm of body phosphorus control has been that regulation of phosphorus was secondary to the tighter control of calcium. Animals 2020, 10, 1806 is an extensive regulatory system to control body phosphorus by proteins known as phosphatonins [1]. This system is centered on fibroblast growth factor 23 (FGF23), a hormone that is produced by osteocytes in response to high plasma phosphorus concentrations [2]. FGF23 forms a complex with α-klotho (klotho) and fibroblast growth factor receptor 1c (FGFR1c); limited binding to FGFR3 and -4 may occur [3,4]. This leads to downregulation of sodium-phosphate co-transporters The other major effect of FGF23 on plasma phosphorus concentration is via inhibition of 25-hydroxyvitamin D 1α-hydroxylase and, possibly, activation of 25-hydroxyvitamin D

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.